Beyond Weight Loss: Other GLP-1 Uses (PCOS, Alcohol, Pregnancy & More)

Approved, off-label, or still in research?

Most of the questions people ask online about "other" GLP-1 uses fall into three buckets, and keeping them straight is the most important thing on this page. An FDA-approved use means the drug has been formally tested and authorized for that purpose. An off-label use is legal and often appropriate, but it means a clinician is prescribing the drug for something it wasn't specifically approved to treat, based on their judgment and the available evidence. An investigational use is one still being studied in clinical trials — promising signals, but not yet proven or approved.

Here is how the most-searched uses sort out as of 2026. The detail behind each row follows below.

Can GLP-1s help with PCOS?

This is one of the most common questions, and the honest answer is: likely yes for many people, but off-label. Polycystic ovary syndrome (PCOS) is closely tied to insulin resistance and weight, and those are exactly the levers GLP-1 drugs pull. By improving insulin sensitivity and supporting weight loss, GLP-1 medications can ease several PCOS-related problems — and for some people, that improvement helps restore more regular ovulation and menstrual cycles.

What they are not is an FDA-approved PCOS treatment. There's no GLP-1 drug labeled specifically for PCOS, so any prescription for that purpose is off-label. Clinicians may consider it, often alongside or instead of older options like metformin, particularly when weight and insulin resistance are driving symptoms. Because PCOS care is individual — and because improved fertility has real implications (see "Ozempic babies" below) — this is a decision to make with a gynecologist or endocrinologist who can monitor you, not one to self-start.

Do GLP-1s reduce alcohol cravings or treat alcohol use disorder?

Few "other uses" have generated as much buzz. Many people on GLP-1 drugs spontaneously report that they want to drink less, and some describe alcohol losing its appeal entirely. Early research is genuinely promising: the same brain reward pathways that drive "food noise" appear to be involved in cravings for alcohol, and small studies and trials have begun to test whether GLP-1 drugs reduce drinking.

But "promising" is not "proven." As of 2026, no GLP-1 medication is FDA-approved to treat alcohol use disorder, and clinical trials are still underway to establish whether the effect is real, how large it is, and who it helps. If you're struggling with alcohol, the right move is not to obtain a GLP-1 drug for that purpose on your own — it's to talk to a clinician about evidence-based treatments for alcohol use disorder, and to raise GLP-1 research as one of the things you'd like to discuss.

Can GLP-1s help with binge eating disorder?

GLP-1 drugs blunt appetite and quiet the constant background pull toward food that many people call "food noise," so it's intuitive that they might help with binge eating disorder (BED). Some clinicians do use them off-label for this, particularly when BED coexists with obesity. Anecdotal reports and early data point toward reduced binge frequency for some people.

The evidence here is still limited, however, and BED is a psychiatric condition with established, well-studied treatments — including specific therapies and an FDA-approved medication. A GLP-1 drug is not a substitute for that care, and disordered eating can be made worse, not better, by aggressive appetite suppression in the wrong context. If binge eating is the concern, loop in a clinician who treats eating disorders before adding or relying on a GLP-1 medication.

Are GLP-1s safe during pregnancy or while trying to conceive?

Short answer: no, and this is one of the clearest cautions in the whole class. GLP-1 medications are not recommended during pregnancy. Animal studies showed potential harm to the developing fetus, and there isn't enough human safety data to use them while pregnant.

Because these drugs can stay in your system for a while, guidance is to stop before trying to conceive, allowing a washout period first. For semaglutide, for example, the common recommendation is to discontinue roughly two months before a planned pregnancy. Exact timing depends on the specific medication and your situation, so plan it with your clinician rather than guessing. If you're of reproductive age and on a GLP-1 drug, talk through both reliable contraception while you're taking it and a clear stop-and-switch plan if you want to get pregnant.

What are "Ozempic babies"?

"Ozempic babies" is the nickname that spread across social media for the wave of unexpected pregnancies reported by people on GLP-1 drugs. There are two plausible explanations, and they may both be at play.

• Restored fertility. Weight loss and improved insulin sensitivity can restore ovulation in people who weren't ovulating regularly — especially those with PCOS. In other words, the drug may be quietly making someone more fertile than they expected.
• Reduced birth-control effectiveness (tirzepatide). Tirzepatide's prescribing information notes that it may reduce the effectiveness of oral contraceptives. The advice is to use a backup method or switch to a non-oral form of contraception when starting tirzepatide or increasing the dose.

The practical takeaway is simple: if you don't want to get pregnant, don't assume your current contraception is enough just because it was before. And if you might want to get pregnant, the same biology is good news — but you'll still need to plan a safe stop before conceiving.

Can GLP-1s help with perimenopause weight gain?

Weight gain around perimenopause is extremely common and frustrating, driven by shifting hormones, changes in body composition, sleep disruption and more. GLP-1 drugs can help with weight in this stage of life much as they do otherwise — but the key phrase is under medical supervision, and as one part of a bigger picture.

A good clinician will look at the whole context: hormonal changes (and whether menopausal hormone therapy is appropriate), sleep, muscle mass, activity and nutrition, not just the number on the scale. Using a GLP-1 drug for perimenopausal weight is off-label unless you also meet the approved criteria for weight management, so it's worth confirming both the medical fit and the practical questions like cost and coverage with your clinician.

Can teenagers take GLP-1 medications?

Yes — and unlike most uses on this page, this one is FDA-approved. For adolescents with obesity, Wegovy (semaglutide) and Zepbound (tirzepatide) are approved for ages 12 and up, and Saxenda (liraglutide) is approved for ages 12 and up as well.

That approval comes with important context. These medications are used alongside lifestyle therapy — nutrition, activity and behavioral support — not as a shortcut around it, and they're meant to be managed under specialist care, typically a pediatric obesity or endocrinology program. The decision to start a teenager on a GLP-1 drug is a careful, individualized one that weighs the health risks of obesity against the medication's effects and the fact that long-term data in young people is still accumulating.

How do GLP-1s interact with antidepressants and ADHD medications?

This comes up constantly, because so many people take GLP-1 drugs alongside an antidepressant, an ADHD stimulant, or both. The reassuring part: GLP-1 medications are generally usable together with these drugs. There's no blanket rule against combining them.

The wrinkle is that GLP-1 drugs slow gastric emptying, which can change how quickly and completely your stomach absorbs oral medications. For most drugs this is minor, but it can affect timing and absorption, and it's exactly why your prescriber needs the full list of everything you take. Give them the complete picture — antidepressants, ADHD medications, contraceptives, supplements and anything else — so they can monitor for changes in how your other medications are working and adjust if needed.

Are GLP-1s being studied for Alzheimer's, inflammation, or chronic pain?

Yes, and this is one of the most exciting frontiers — but it's firmly in the "in research" bucket. The most prominent example is Alzheimer's disease: semaglutide is being tested in large clinical trials for people with early Alzheimer's, including the EVOKE trial program, on the theory that GLP-1's effects on metabolism, inflammation and the brain might slow cognitive decline.

Beyond that, researchers are investigating GLP-1 drugs' apparent anti-inflammatory effects and their potential roles in conditions ranging from liver disease to chronic pain. Some of this work is early and some is well underway, but the bottom line is the same: none of these are FDA-approved indications yet. Headlines about a "wonder drug" for the brain or for inflammation are describing hopeful research, not established treatment.

The bottom line

GLP-1 drugs are turning out to be far more versatile than "weight-loss shots," and the science is moving quickly. But the further you get from their approved uses, the more important your clinician becomes. PCOS, binge eating and perimenopausal weight are off-label territory where a knowledgeable prescriber can weigh the trade-offs with you. Alcohol use, Alzheimer's, inflammation and chronic pain are still research questions, not treatments you can count on. And the pregnancy and contraception cautions are not optional fine print — they're central to using these drugs safely.

If any of these uses applies to you, the best next step is a focused conversation with your own clinician. To go deeper on the basics, see what GLP-1 actually is, how it drives weight loss, the side effects to know, the specific medications, and the pill-versus-injection trade-offs.

Frequently asked questions